Necrotizing myopathy: Clinicoserologic associations

Muscle and Nerve

Volumn 45, Issue 2, 2012, Pages 189-194

  Ellis, Elizabeth ^a   Tan, Ju Ann ^b   Lester, Sue ^c   Tucker, Graeme ^d   Blumbergs, Peter ^e   Roberts Thomson, Peter ^b   Limaye, Vidya ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

^c QUEEN ELIZABETH HOSPITAL   (Australia)

^d Government of South Australia   (Australia)

^e INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

Anti SRP autoantibodies; Idiopathic inflammatory myopathy; Myositis associated antibodies; Necrotizing myopathy; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; CREATINE KINASE; PREDNISOLONE;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; AUSTRALIA; CANCER RISK; CLINICAL FEATURE; COMORBIDITY; CREATINE KINASE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MYALGIA; MYOPATHY; NECROTIZING MYOPATHY; PRIORITY JOURNAL; SERODIAGNOSIS; SEX RATIO; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CREATINE KINASE, MM FORM; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MYOSITIS; ONLINE SYSTEMS; SOUTH AUSTRALIA; YOUNG ADULT;

EID: 84855824480     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.22279     Document Type: Article

References (31)

1. Limaye VS, Blumbergs P, Roberts-Thomson PJ. Idiopathic inflammatory myopathies. Intern Med J 2009;39:179-190.
2. Sadeh M, Dabby R. Steroid-responsive myopathy: immune-mediated necrotizing myopathy or polymyositis without inflammation? J Clin Neuromuscul Dis 2008;9:341-344.
3. Bronner IM, Hoogendijk JE, Wintzen AR, van der Meulen MF, Linssen WH, Wokke JH, et al. Necrotizing myopathy, an unusual presentation of a steroid-responsive myopathy. J Neurol 2003;250:480-485.
4. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-347.
5. Bohan A, Peter JB, Bowman RL, Pearson CM. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977;56:255-286.
6. Limaye V BP, Scott G, Roberts-Thomson P. The clinical features of dermatomyositis in a South Australian population. APLAR J Rheumatol 2007;10:86-93.
7. Targoff IN. Humoral immunity in polymyositis/dermatomyositis. J Invest Dermatol 1993;100(suppl):116S-123S.
8. Ghirardello A, Zampieri S, Tarricone E, Iaccarino L, Bendo R, Briani C, et al. Clinical implications of autoantibody screening in patients with autoimmune myositis. Autoimmunity 2006;39:217-221.
9. Koenig M, Fritzler MJ, Targoff IN, Troyanov Y, Senecal JL. Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes. Arthritis Res Ther 2007; 9:R78.
10. Brouwer R, Hengstman GJ, Vree Egberts W, Ehrfeld H, Bozic B, Ghirardello A, et al. Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 2001;60:116-123.
11. Reeves WH, Nigam SK, Blobel G. Human autoantibodies reactive with the signal-recognition particle. Proc Natl Acad Sci USA 1986;83: 9507-9511.
12. Hengstman GJ, Brouwer R, Egberts WT, Seelig HP, Jongen PJ, van Venrooij WJ, et al. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies. J Neurol 2002;249:69-75.
13. Miller T, Al-Lozi MT, Lopate G, Pestronk A. Myopathy with antibodies to the signal recognition particle: clinical and pathological features. J Neurol Neurosurg Psychiatry 2002;73:420-428.
14. Hengstman GJ, ter Laak HJ, Vree Egberts WT, Lundberg IE, Moutsopoulos HM, Vencovsky J, et al. Anti-signal recognition particle autoantibodies: marker of a necrotizing myopathy. Ann Rheum Dis 2006; 65:1635-1638.
15. Kao AH, Lacomis D, Lucas M, Fertig N, Oddis CV. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy. Arthritis Rheum 2004;50:209-215.
16. Hohlfeld R. Polymyositis and dermatomyositis. In: Karpati G, editor. Muscle biopsy: a practical approach. Basel: ISN Neuropath Press; 2002.
17. Breslow NE, Day N. Statistical methods in cancer research: Vol. II. The design and analysis of cohort studies. New York: Oxford University Press; 1986.
18. Limaye VS, Lester S, Blumbergs P, Roberts-Thomson PJ. Idiopathic inflammatory myositis is associated with a high incidence of hypertension and diabetes mellitus. Int J Rheum Dis 2010;13:132-137.
19. Amato AA, Barohn RJ. Evaluation and treatment of inflammatory myopathies. J Neurol Neurosurg Psychiatry 2009;80:1060-1068.
20. van der Pas J, Hengstman GJ, ter Laak HJ, Borm GF, van Engelen BG. Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies. J Neurol Neurosurg Psychiatry 2004;75:136-139.
21. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003;362:971-982.
22. Nagaraju K, Raben N, Merritt G, Loeffler L, Kirk K, Plotz P. A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli. Clin Exp Immunol 1998;113:407-414.
23. Lundberg I, Ulfgren AK, Nyberg P, Andersson U, Klareskog L. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis Rheum 1997;40:865-874.
24. Lepidi H, Frances V, Figarella-Branger D, Bartoli C, Machado-Baeta A, Pellissier JF. Local expression of cytokines in idiopathic inflammatory myopathies. Neuropathol Appl Neurobiol 1998;24:73-79.
25. Grable-Esposito P, Katzberg HD, Greenberg SA, Srinivasan J, Katz J, Amato AA. Immune-mediated necrotizing myopathy associated with statins. Muscle Nerve 2010;41:185-190.
26. Christopher-Stine L, Casciola-Rosen LA, Hong G, Chung T, Corse AM, Mammen AL. A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. Arthritis Rheum 2010;62:2757-2766.
27. Mammen AL, Chung T, Christopher-Stine L, Rosen P, Rosen A, Casciola- Rosen LA. Autoantibodies against 3-hydroxy-3-methylglutarylcoenzyme a reductase (HMGCR) in patients with statin-associated autoimmune myopathy. Arthritis Rheum 2011;63:713-721.
28. Stockton D, Doherty VR, Brewster DH. Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer 2001;85:41-45.
29. Buchbinder R, Forbes A, Hall S, Dennett X, Giles G. Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population- based cohort study. Ann Intern Med 2001;134:1087-1095.
30. Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, Evans SR, Felson DT. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 2001; 357:96-100.
31. Levin MI, Mozaffar T, Al-Lozi MT, Pestronk A. Paraneoplastic necrotizing myopathy: clinical and pathological features. Neurology 1998; 50:764-767